Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Tag
Assay Development Remove


April 2014
Su Sa Fr Th We Tu Mo
20 19 18 17 16 15 14

assay development Press Releases

  + XML/RSS  



By Biotech Support Group LLC
Cholesterol removal from serum samples using Cleanascite™ for immunogenicity and safety endpoint analysis of pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine.

By BBInternational
The BBI Group is determined to steal the show at this year’s American Association for Clinical Chemistry event with the launch of its new hand held reader and end to end IVD assay development solution.

By Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI) is pleased to offer this pre-conference short course on Tuesday, November 15 at the DoubleTree Hotel in Bethesda, MD.

By Cambridge Healthtech Institute
A 2-part event covering developments in assay technologies, risk assessment, regulatory guidance and means of predicting and avoiding immunogenicity. Early registration discounts will be offered until August 26.

By Sara Pierre
tebu-bio is pleased to be participating at the ELA Screening Europe conference which will take place in Hamburg from June 30th to July 1st, 2011

By GTCbio
This conference will also provide a venue for professionals in the drug discovery industry and academics to get an update of exciting new developments in assay technologies and exchange ideas in developing creative approaches in the drug discovery

By Steve Dubin
ECI Biotech of Worcester, MA, a premier developer of low cost and rapid diagnostics trademarked as ExpressDetect, has received a $511K Phase II Grant to develop a hand-held diagnostic tool for point-of-care detection of infection in chronic wounds.

By GenScript USA Inc./Sally Wang
GenScript expands its drug discovery services to assay development.

By Steve Dubin
The presentation highlighted ECI Biotech’s patented ExpressDetect Diagnostic technology that enables rapid, easy detection of microbial pathogens. Target markets include: feminine care, wound care, oral care, and hospital infection control.

By GTCbio
Dr. Taosheng Chen, Director of HTS, St. Jude Children's Research Hospital will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA.

By GTCbio
Dr. Xi Chen, Assistant Professor in the Department of Chemistry at the University of California, Davis will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA

By GTCbio
Dr. John W. Cuozzo, Director of ELT Lead Discovery at GlaxoSmithKline will present at GTCbio’s 3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San Francisco, CA.

By GTCbio
Hakim Djaballah, Director of HTS at Memorial Sloan Kettering Cancer Center to Present at GTCbio’s 3rd Assay Development & Screening Technologies Conference, June 5-6, 2008 in San Francisco, CA



Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share